Skip to main content
. Author manuscript; available in PMC: 2011 Jun 6.
Published in final edited form as: Autoimmunity. 2008 Sep;41(6):442–453. doi: 10.1080/08916930802031579

Figure 2.

Figure 2

Anti-human cardiac myosin titers (IgG) of diabetic cardiomyopathy sera compared with diabetic sera and normal control donors in the ELISA. Diabetic cardiomyopathy sera titers were significantly higher than in diabetic (p ≤ 0.0001) and control (p = 0.01) sera groups.